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ABSTRACT 
Background: Previous research demonstrates various associations between depression, 
cardiovascular disease (CVD) incidence and mortality, possibly as a result of the different 
methodologies used to measure depression and analyse relationships. This analysis investigated the 
association between depression, CVD  incidence (CVDI) and mortality from CVD (MCVD), smoking 
related conditions (MSRC), and all causes (MALL), in a sample data set, where depression was 
measured using items from a validated questionnaire and using items derived from the factor 
analysis of a larger questionnaire, and analyses were conducted based on continuous data and  
grouped data. 
Methods: Data from the PRIME Study (N=9,798 men) on depression and ten year CVD incidence and 
mortality were analysed using Cox proportional hazards models.  
Results: Using continuous data, both measures of depression resulted in the emergence of positive 
associations between depression and mortality (MCVD, MSRC, MALL). Using grouped data, however, 
associations between a validated measure of depression and MCVD, and between a measure of 
depression derived from factor analysis and all measures of mortality were lost. 
Limitations: Low levels of depression, low numbers of individuals with high depression and low 
numbers of outcome events may limit these analyses, but levels are usual for the population 
studied. 
Conclusions: These data demonstrate a possible association between depression and mortality but 
detecting this association is dependent on the measurement used and method of analysis. Different 
findings based on methodology present clear problems for the elucidation and determination of 
relationships. The differences here argue for the use of validated scales where possible and suggest 
against over-reduction via factor analysis and grouping. 
 
Depression, cardiovascular disease, mortality, methodology, questionnaires, statistical analysis 
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INTRODUCTION 
Various researchers report a link between depression, cardiovascular disease, and mortality, while 
others also report no association, or an association that results purely from confounders (see 
Atlantis et al, 2012; Baune et al, 2012; Leung et al, 2012; Schulz et al, 2002; Wulsin et al, 1999). 
These different conclusions between studies are often attributed partly to differing methodologies. 
Studies investigating methodological effects have largely focussed on details such as depression 
subtype, time course effects, and confounding variables (Atlantis et al, 2012; Baune et al, 2012; 
Leung et al, 2012; Schulz et al, 2002; Wulsin et al, 1999), but two purely methodological aspects of 
limited study include the method by which depression is assessed and the analyses subsequently 
conducted. Measures of depression can range from clinical interviews to self-rating scales and single 
questions (Nezu et al, 2000). Analyses can be conducted using continuous data, allowing the 
emergence of continuous patterns and effects, or data which is grouped dichotomously as 
depressed / not depressed, or grouped by quartiles or quintiles, which may more easily elucidate 
extreme differences and detect non-linear associations (Kline, 2000; Biswas et al, 2008). Use of 
different methods of measurement and analysis could potentially result in different outcomes. This 
analysis aimed to investigate the link between depression, cardiovascular disease incidence and 
mortality in a sample data set, when comparing the use of items from a validated questionnaire and 
items from the factor analysis of a larger questionnaire for the assessment of depression, and using 
analyses based on continuous data and grouped data. 
 
METHODS 
Analyses were conducted on the data set gained from the Prospective Epidemiological Study of 
Myocardial Infarction (PRIME) study, where data on depression, cardiovascular disease incidence 
and mortality are available over a ten year follow-up period for 9,798 men from France and 
Northern Ireland. Full details of the PRIME study are provided elsewhere (The PRIME Study Group, 
1998). 
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Depression was assessed in the PRIME study using 10 questions from a validated questionnaire – the 
Welsh Pure Depression Inventory (Rodda et al, 1971), plus three additional questions, all contained 
within a larger 70 item psychosocial questionnaire. The psychosocial questionnaire was derived by 
including questions from a number of validated questionnaires - the Framingham Type A scale 
(Haynes et al, 1978), the Cook-Medley Hostility scale (Cook & Medley, 1954) and the MONICA scales 
for the assessment of social support (WHO, 1989), plus additional questions derived by researchers 
(Sykes et al, 2002). The questionnaire was completed by all participants at the start of the study. 
 
Data on depression via a validated questionnaire were obtained by combination of the 10 items 
from the Welsh Pure Depression Inventory. Questions were responded to on a 2 point scale (true / 
false: scored 1 / 0), then combined and divided by the number of questions to result in a single 
depression score (depV) per person between 0 and 1, where higher scores denote greater 
depression. Individual questions are provided in Table 1. All questions were responded to using the 
full extent of possible answers.  
 
Data on depression via the factor analysis were obtained through principal component analysis (with 
varimax rotation) on 69 items from the psychosocial questionnaire. (One item was optional and due 
to low response rates was excluded from the analysis). This analysis revealed eight factors, 
explaining 37% of the variance, but inspection of individual factor loadings and composite factors, 
and reference to an earlier analysis of the same dataset (Sykes et al, 2005) resulted in a decision to 
limit the analysis outcomes to five factors, explaining 29% of the variance. These five factors utilised 
58 items from the questionnaire. All items with a factor loading less than 0.30 on any factor were 
ignored. Based on their component questions, these factors were labelled Depression (16 items), 
Competitiveness (14 items), Hostility (10 items), Social Support (8 items) and Anger / Impatience (10 
items). Individual questions for the Depression factor are provided in Table 2. Cronbach’s alpha for 
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reliability = 0.71. All questions were responded to using a variety of response formats, but all 
response formats were subsequently re-scaled to result in a score per question of between 0 and 1. 
All questions were responded to using the full extent of possible answers. Scores on the depression 
factor were created per person by adding  scores for all relevant items and dividing by the number of 
items, to result in a score (depFA) between 0 – 1, where higher scores again denote greater 
depression.  
 
Tables 1 and 2 about here 
 
For the analyses, either calculated continuous depression scores (depV / depFA) were used, or 
depression scores were grouped into approximate fifths (depVG / depFAG). Grouping into exact 
quintiles was not possible due to the limited gradations and responses in the depression scales.  
 
Cardiovascular disease incidence (CVDI), mortality (MCVD), mortality from smoking related 
conditions (MSRC) and mortality from all causes (MALL) were assessed for a ten year period from 
the start of the study via hospital records. All reported cases were verified by study personnel (The 
PRIME Study Group, 1998). 
 
Cox proportional hazards models were used to predict incidence or not of CVDI, MCVD, MSRC and 
MALL using depression scores (Model 1), depression scores plus two demographic confounders 
(Model 2), and depression scores, demographic confounders and ten lifestyle confounders known to 
be associated with mortality (Model 3) (The PRIME Study Group, 1998; Wulsin et al, 1999; Schulz et 
al, 2002). The two demographic confounders were age and country of residence (NI / France). The 
ten lifestyle confounders were: systolic blood pressure, cholesterol, HDL cholesterol, height, BMI, 
fruit and vegetable intakes (portions of fruit, fruit juice and vegetables / day), physical activity 
(metabolic equivalent scores / week), lifetime smoking (five categories: never smoked; smoked other 
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than cigarettes; smoked less than 15 cigarette pack-years; smoked 15 or more but less than 30 
cigarette pack-years; smoked 30 or more cigarette pack-years), alcohol (five categories: none; 1-
128ml/week; 129-265ml/week; 266-461ml/week; and 462ml or more/week) and diabetes 
(present/absent). Similar analyses were conducted using continuous data and using grouped data. 
The grouped analyses investigated evidence of a linear trend to allow comparison with continuous 
data. Analyses were also attempted using two groups (depressed / not depressed), but cut offs for 
depression / no depression are not available for the Welsh Pure Depression Inventory (Rodda et al, 
1971), and are clearly not available for the scale derived from factor analysis. Analyses were 
conducted for two groups using scores of 0 vs 0.1 or more on each scale, but this resulted in 
classification of 60% of the sample as depressed using depV, and 84% of the sample as depressed 
using depFA. These proportions of depressed / not depressed are neither comparable between 
scales nor with other reports of depression incidence (APA, 2000). Analyses were also conducted 
using a cut-off score for depFA that resulted in classification of 60% of the sample as depressed, as 
was similar for depV, but this number of depressed individuals is again not comparable with other 
reports on depression incidence (APA, 2000). Analyses were conducted only on participants who 
were free from cardiovascular disease at the start of the study, and who provided scores for both 
depV and depFA variables.  
 
RESULTS 
A total of 8,138 men provided data for both depV and depFA and were included in analyses. Detailed 
descriptive statistics for the sample are provided in Table 3. Using the validated questionnaire, mean 
+/- st.dev. depV score for the sample was 0.15 +/- 0.18 ranging from 0 – 1, and using factor analysis, 
mean +/- st.dev. depFA score for the sample was 0.23 +/- 0.18, ranging from 0 – 1. DepV and depFA 
scores correlated very well (r=0.908, p<0.01) (see Figure 1), but depFA scores were consistently 
higher than depV scores (paired samples t-test t(8137)=95.01, p<0.001). Detailed descriptive 
statistics by group (depVG and depFAG) are also provided in Table 4. Number of cases of CVDI = 372, 
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MCVD = 59, MSRC = 177, and MALL = 419, were obtained in a total observation time of 78,493 
person years. Number of events and event rate, in total and by depression category are provided in 
Table 5.  
 
Tables 3 - 5 about here 
Figure 1 about here 
 
Hazards ratios, confidence intervals and significance for all depV, depFA, depVG and depFAG 
relationships are displayed in Tables 6 and 7, respectively. 
 
Using continuous data, both depV and depFA were associated with CVDI independently and when 
demographic variables were included in the model, but not when lifestyle variables were also 
included. Both depV and depFA were associated with MCVD, MSRC and MALL in all three models, 
although effects in all models were more significant using depV than depFA.  
 
Table 6 about here 
 
Using grouped data, similar patterns were found with depVG as were found with depV, but no 
associations were found between depVG and MCVD in any model. Unlike results for depFA, depFAG 
was not associated with CVDI or MCVD in any model, and depFAG was only associated with MSRC 
and MALL, independently and when demographic variables were included in the model, but not 
when lifestyle variables were also included.  
 
Table 7 about here 
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Using depressed / not depressed groups, similar patterns were found as were found using five 
categories (depVG / depFAG) (data not shown).  
 
DISCUSSION 
Different associations were found dependent on measurement of depression and analysis used. 
 
Comparable results were found using the two depression measures when analysed using continuous 
data. Using both measures, depression at baseline was associated with mortality from CVD, from 
smoking-related conditions, and from all causes up to ten years later, where greater depression is 
associated with increased risk. Comparable findings from the validated questionnaire and the scale 
derived by factor analysis are reassuring and suggest the derivation and use of a single ‘depression’ 
concept by factor analysis, despite the use of eight items from the validated questionnaire plus an 
additional eight items derived by researchers. The scale derived by factor analysis clearly depends on 
the other items used in the whole questionnaire, both in terms of inclusion (items that are included 
in one scale) and exclusion (items that become more associated with other scales), plus the 
interpretation of the analyst (Kline, 2000; Coaley, 2010). It shouldn’t be forgotten that factor analysis 
is a statistical method for grouping questionnaire items that are subsequently described by a label, 
and the accuracy of the label is far from guaranteed (Kline, 2000; Coaley,2010). Compared to this, a 
questionnaire or questionnaire items that have been validated against a clinical diagnosis, agreed 
clinical symptoms or using clinical treatments may offer increased accuracy, reliability and validity 
(Kline, 2000).  
 
Different findings, however, emerged when data were grouped. Using data from the validated 
questionnaire, associations between depression and MCVD were lost with the use of grouped data, 
although all other relationships remained. Using data from the factor analysis, grouping (depFAG) 
resulted in the loss of all associations between depression and CVDI and MCVD, and of the 
9 
 
associations between depression and MSRC and MALL once lifestyle variables were taken into 
account. These results suggest that the reduction of data, via both factor analysis and grouping, can 
result in the loss of relationships that are apparent using analyses of continuous data. Loss of 
associations may have occurred for a number of statistical reasons, including the coherence of the 
factor, the strength of the association, and the variance in the data (Kline, 2000). MCVD results 
based on grouped data are also likely to have been affected by the small number of cases available, 
and some of the differences between depVG and depFAG results may have arisen as a result of 
differences in categorization. It is noticeable that the depVG data was more difficult to categorize 
evenly, due to the presence of fewer gradations in this scale.  
 
The stronger associations using depV and depVG than using depFA and depFAG scales may also 
demonstrate the provision of a cleaner or purer measure of depression using the items from the 
validated measure than the scale derived by factor analysis, or a more complete capture of the 
aspects of depression most pertinent to mortality. The difference in question items in the two scales 
are provided in Tables 1 and 2, and it is noteworthy that almost half of those in the scale derived by 
factor analysis were not originally provided by a questionnaire purporting to measure depression. 
The majority of the remaining questions are sleep-related, and disruptions to sleep are symptomatic 
of a number of conditions other than depression (APA, 2000).  
 
The potential implications of these differing conclusions from the same data set, as a result purely of 
measurement and analyses, are obvious. Based on the same questionnaire responses, analyses using 
continuous data result in the demonstration of a relationship between depression and mortality 
from cardiovascular disease, smoking related conditions and all causes, whereas analyses using 
grouped data result in the reporting of no association. Associations and no associations between 
depression and mortality have previously been reported elsewhere (Atlantis et al, 2012; Baune et al, 
2012; Leung et al, 2012; Schulz et al, 2002; Wulsin et al, 1999). The findings of this study however 
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suggest that no associations may have previously been reported, purely as a result of an over-
reduction of data. These conclusions may suggest greater need or prefential use of analyses 
conducted on continuous data.  
 
Limitations 
The results of this analysis clearly depend on the factor analysis, which in turn depends on the 
questionnaire used and our interpretation of results. Different questionnaires and interpretations 
could result in different conclusions, but this is the point of this paper. The analysis may also be 
limited however, by the low levels of depression, the low number of people suffering from severe 
depression, and the low levels of outcome events. Levels in this study however are usual for the 
populations studied. 
 
Conclusions 
These data demonstrate possible associations between depression and mortality, but the detection 
of these associations is dependent on the measurement used and method of analysis. To allow 
relationships to be accurately reported, there is a clear need here for the use of standardised 
methods and analyses. The objectivity, reliability and validity of validated measures argue for the 
use of validated scales where possible. The increased appearance and clarity of associations where 
these exist argue for the use of continuous data and suggest against over-reduction.  
 
REFERENCES 
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders 4th ed. Text 
Revision. Washington DC, American Psychiatric Association, 2000.  
 
11 
 
Atlantis, E., Shi, Z., Penninx, B.J.W.H., Wittert, G.A., Taylor, A., Almeida, O.P. 2012. Chronic medical 
conditions mediate the association between depression and cardiovascular disease mortality. Social 
Psychiatry and Psychiatric Epidemiology, 47, 615-25 
 
Baune, B.T., Stuart, M., Gilmour, A., Wersching, H., Arolt, V., Berger, K. 2012. Moderators of the 
relationship between depression and cardiovascular disorders: a systematic review. General Hospital 
Psychiatry 34, 478-92 
 
Biswas, A., Datta, S., Fine, J.P. Segal, M.R. 2008. Statistical Advice in the Biomedical Sciences: Clinical 
trials, epidemiology, survival analysis, and bioinformatics. Hoboken, NJ, USA: Wiley Interscience. 
 
Coaley, K. 2010. An introduction to psychological assessment and psychometrics. London: Sage 
Publications Ltd. 
 
Cook, W.W., Medley, D.M. 1954. Proposed hostility and pharisaic-virtue scales for the MMPI. J 
Applied Psychol. 38, 414-18 
 
Haynes, S.G., Levine, S., Scotch, N., et al. 1978.The relationship of psychosocial factors to coronary 
heart disease in the Framingham study.Methods and risk factors. Am J Epidemiol 107, 362-83 
 
Kline, P. 2000. The Handbook of Psychological Testing. London: Routledge. 
 
Leung, Y.W., Flora, D.B., Gravely, S., Irwine, J., Carney, R.M., Grace, S.L. 2012. The impact of 
premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients 
with coronary heart disease: Meta-analysis. Psychosomatic Medicine 74, 786-801 
 
12 
 
Nezu, A.M., Ronan, G.F., Meadows, E.A., McClure, K.S. 2000. Practitioers Guide to Empirically Based 
Measures of Depression. London: Kluwer Academic Publishers. 
 
Rodda, B.E., Miller, M.C., Bruhn, J.G. 1971. Prediction of anxiety and depression patterns among 
coronary patients using a Markov process analysis.BehavSci 16, 482-89 
 
Schulz, R., Drayer, R.A., Rollman, B.L. 2002. Depression as a risk factor fornon-suicide mortality in the 
elderly. Biol Psychiatry 52, 205–25. 
 
Sykes, D.H., Arveiler, D., Salters, C.P., et al. 2002. Psychosocial risk factors for heart disease in 
Northern Ireland and France: The Prospective Epidemiological Study of Myocardial Infarction 
(PRIME). International Journal of Epidemiology, 31,1227-1234 
 
The PRIME Study Group. 1998. The PRIME Study: classical risk factors do not explain the severalfold 
differences in risk of coronary heart disease between France and Northern Ireland. Quart J Medicine, 
91, 667-76. 
 
World Health Organization. 1989. MONICA Psychosocial Optional Study. Suggested Measurement 
Instruments. Copenhagen: WHO Regional Office for Europe. 
 
Wulsin, L.R., Vaillant, G.E., Wells, V.E. 1999. A systematic review of the 
mortalityofdepression.Psychosom Med. 61, 6 –17 
 
 
  
13 
 
Table 1: Question items from the Welsh Pure Depression Inventory (Rodda et al, 1971) 
Item  
1 I get tired for no reason 
2 Life seems dull to me 
3 I do not seem to have the energy to do things 
4 I have a good appetite 
5 I am usually bored 
6 I feel that others would be better off if I were dead 
7 I awake in the morning feeling tired 
8 I have trouble sleeping at night 
9 In thinking of my life I often wonder why I exist 
10 I feel useless 
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Table 2: Question items for the Depression scale derived by Factor Analysis from the 70 item 
Psychosocial Questionnaire 
Item  
1 I get tired for no reason 
2 Life seems dull to me 
3 I do not seem to have the energy to do things 
4 I am usually bored 
5 I awake in the morning feeling tired 
6 I have trouble sleeping at night 
7 In thinking of my life I often wonder why I exist 
8 I feel useless 
9 I feel powerless to effect changes in my life 
10 I feel helpless 
11 I often feel uncertain, uncomfortable or dissatisfied with how well I am doing 
12 How often in the last month, did you have trouble falling asleep? 
13 How often in the last month, did you have trouble staying asleep (e.g. waking up too early)? 
14 How often in the past month, did you wake up two or more times per night? 
15 How often in the past month, did you wake up after your usual amount of sleep feeling 
tired and worn out? 
16 How many hours of sleep do you usually get each night? 
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Table 3: Descriptive statistics (mean, st.dev., minimum, maximum, or %) for depression, 
demographic and lifestyle variables for the whole sample (N=8138). 
 Mean St. Dev. Minimum Maximum 
DepV score (0-1) 0.15 0.18 0 1 
DepFA score (0-1) 0.23 0.18 0 1 
Age (years) 54.8 2.9 48 64 
Systolic blood pressure (mm Hg) 133.6 18.8 79 226 
Cholesterol  (mg/dl) 2.22 0.38 0.79 6.15 
HDL cholesterol (mg/dl) 0.49 0.13 0.10 1.50 
Height (m) 1.73 0.07 1.43 2.00 
BMI (kg/m2) 26.5 3.4 15.8 47.6 
Fruit and vegetable intakes (portions of 
fruit, fruit juice and vegetables / day) 
2.6 1.4 0 21 
Physical activity (metabolic equivalent 
scores / week) 
96 66 0 528 
Country of residence (%) France  - 74; Northern Ireland - 26 
Lifetime smoking (% per category) never smoked - 30;  
smoked other than cigarettes - 8;  
smoked less than or equal to 15 cigarette pack-years -22;  
smoked 16  - 30 cigarette pack-years - 19;  
smoked 31 or more cigarette pack-years –21. 
Alcohol (% per category)  none - 17; 1-128ml/week - 22; 129-265ml/week - 22; 266-
461ml/week - 19; and 462ml or more/week –20. 
Diabetes (% present) 3 
Disease or mortality (N of cases)  CVDI = 372; MCVD = 59; MSRC = 177; MALL = 419 
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Table 4: Descriptive statistics (mean and standard deviation or %) for depression, demographic and 
lifestyle variables in five categories of DepVG and DepFAG. 
 DepVG 
N=3283 
(40%) 
DepVG1 
N=1880 
(23%) 
DepVG2 
N=1193 
(15%) 
DepVG3 
N=761 
(9%) 
DepVG4 
N=1021 
(13%) 
 
DepV score (0-1) 0.00 (0.00) 0.10 (0.00) 0.20 (0.00) 0.30 (0.00) 0.52 (0.14) <0.001 
DepFA score (0-1) 0.09 (0.05) 0.19 (0.08) 0.29 (0.08) 0.37 (0.09) 0.56 (0.15) <0.001 
Age (years) 54.8 (2.9) 54.8 (2.9) 54.8 (2.9) 54.8 (2.8) 54.5 (2.8) 0.06 
Systolic blood pressure (mm Hg) 133 (19) 134 (19) 134 (19) 134 (19) 132 (18) 0.05 
Cholesterol  (mmol/L) 2.22 (0.36) 2.21 (0.38) 2.24 (0.39) 2.22 (0.36) 2.20 (0.40) 0.06 
HDL cholesterol (mmol/L) 0.49 (0.12) 0.49 (0.13) 0.48 (0.13) 0.48 (0.13) 0.48 (0.14) 0.27 
Height (cm) 173 (7) 173 (6) 173 (7) 173 (6) 172 (6) 0.01 
BMI (kg/m2) 26.5 (3.1) 26.6 (3.4) 26.7 (3.4) 26.4 (3.5) 26.5 (3.9) 0.42 
Fruit and vegetable intake 
(portions / day) 
 2.7 (1.4)  2.6 (1.4)  2.6 (1.4)  2.5 (1.3)  2.4 (1.4) <0.001 
Physical activity (metabolic 
equivalent scores / week) 
  97 (63)  99 (65)  94 (67)  91 (71)  89 (69) <0.001 
Country of residence (%) 
France 
Northern Ireland 
 
73 
27 
 
76 
24 
 
75 
25 
 
72 
28 
 
75 
25 
0.22 
Lifetime smoking (%) 
never smoked 
smoked other than cigarettes 
less than 15 cigarette pack-years  
15 - 30 cigarette pack-years 
30 or more cigarette pack-years 
 
32 
9 
22 
18 
18 
 
31 
9 
21 
20 
20 
 
29 
7 
23 
18 
23 
 
30 
7 
20 
20 
22 
 
25 
6 
19 
20 
30 
<0.001 
Alcohol (%) 
none 
1-128ml/week 
129-265ml/week 
266-461ml/week  
462ml plus/week 
 
17 
23 
22 
20  
18 
 
15 
21 
23 
21 
20 
 
15 
21 
21 
21 
23 
 
19 
21 
20 
19 
21 
 
20 
21 
19 
16 
23 
<0.001 
Diabetes (%) 3 2 3 4 4 0.003 
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 DepFAG 
N=1789 
(22%) 
DepFAG1 
N=1630 
(20%) 
DepFAG2 
N=1561 
(19%) 
DepFAG3 
N=1618 
(20%) 
DepFAG4 
N=1540 
(19%) 
 
DepV score (0-1) 0.01(0.02) 0.04 (0.05) 0.10 (0.08) 0.20 (0.09) 0.42 (0.18) <0.001 
DepFA score (0-1) 0.05 (0.02) 0.11 (0.02) 0.19 (0.03) 0.30 (0.04) 0.52 (0.13) <0.001 
Age (years) 54.8 (3.0) 54.7 (2.9) 54.9 (2.9) 54.9 (2.8) 54.6 (2.8) 0.01 
Systolic blood pressure (mm Hg) 134 (19) 132 (18) 134 (19) 135 (19) 133 (18) 0.002 
Cholesterol  (mmol/L) 2.22 (0.37) 2.22 (0.36) 2.21 (0.37) 2.23 (0.39) 2.21 (0.39) 0.28 
HDL cholesterol (mmol/L) 0.48 (0.12) 0.49 (0.12) 0.49 (0.13) 0.48 (0.13) 0.49 (0.13) 0.13 
Height (cm) 173 (7) 173 (6) 173 (7) 173 (7) 173 (6) 0.03 
BMI (kg/m2) 26.5 (3.1) 26.4 (3.3) 26.6 (3.3) 26.6 (3.4) 26.6 (3.8) 0.41 
Fruit and vegetable intake 
(portions / day) 
2.7 (1.3) 2.7 (1.5) 2.6 (1.4) 2.6 (1.4) 2.4 (1.3) <0.001 
Physical activity (metabolic 
equivalent scores / week) 
100 (65) 96 (62) 97 (64) 94 (68) 89 (69) <0.001 
Country of residence (%) 
France 
Northern Ireland 
 
28 
72 
 
25 
75 
 
26 
74 
 
26 
74 
 
25 
75 
0.17 
Lifetime smoking (%)  
never smoked 
smoked other than cigarettes 
less than 15 cigarette pack-years  
15 - 30 cigarette pack-years 
30 or more cigarette pack-years 
 
32 
8 
22 
20 
18 
 
31 
9 
22 
18 
20 
 
32 
8 
20 
19 
21 
 
29 
8 
22 
19 
22 
 
27 
7 
21 
19 
26 
<0.001 
Alcohol (%) 
none 
1-128ml/week 
129-265ml/week 
266-461ml/week 
462+ ml/week 
 
19 
24 
20 
19 
18 
 
14 
22 
24 
20 
19 
 
16 
21 
22 
20 
21 
 
15 
21 
22 
20 
22 
 
19 
21 
20 
18 
21 
<0.001 
Diabetes (%) 2 3 3 3 4 0.07 
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Table 5: Number of events and event rates in total, and by categories of depression.  
      CVD Incidence Mortality from CVD 
Mortality from Smoking 
related conditions 
 
Mortality from All Causes 
 
n Person years 
Events 
Rate per 1,000 
person years Events 
Rate per 1,000 
person years Events 
Rate per 1,000      
  person years Events 
Rate per 1,000  
person years 
     
  
 
  
 
  
 
  
 Total 8138 78493 372 4.7 59 0.8 177 2.3 419 5.3 
DepV 
Category 
1 3283 31929 121 3.8 15 0.5 54 1.7 137 4.3 
2 1880 18185 97 5.3 14 0.8 32 1.8 84 4.6 
3 1193 11501 51 4.4 11 1.0 35 3.0 67 5.8 
4 761 7225 44 6.1 7 1.0 21 2.9 54 7.5 
5 1021 9654 59 6.1 12 1.2 35 3.6 77 8.0 
DepFA 
Category 
      
1 1789 17344 73 4.2 14 0.8 36 2.1 88 5.1 
2 1630 15811 65 4.1 4 0.3 25 1.6 63 4.0 
3 1561 15134 72 4.8 11 0.7 26 1.7 75 5.0 
4 1618 15558 79 5.1 14 0.9 46 3.0 92 5.9 
5 1540 14646 83 5.7 16 1.1 44 3.0 101 6.9 
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Table 6: Hazards Ratios, Confidence Intervals and significance for depression and disease or 
mortality relationships using continuous data 
 Unadjusted Adjusted for demographic 
variables
1 
Adjusted for demographic 
and lifestyle variables
2 
 HR CI Sig. HR CI Sig. HR CI Sig. 
DepV          
CVDI 2.18 1.29,3.70 <0.01 2.36 1.39,4.00 <0.01 1.73 0.99,2.99 0.06 
MCVD 4.97 1.55,15.91 0.01 5.83 1.80,18.93 <0.01 4.16 1.22,14.25 0.02 
MSRC 3.64 1.78,7.43 <0.01 4.02 1.96,8.23 <0.01 2.56 1.23,5.34 0.01 
MALL 3.50 2.20,5.56 <0.01 3.86 2.42,6.14 <0.01 2.71 1.68,4.35 <0.01 
DepFA          
CVDI 1.79 1.04,3.11 0.04 1.93 1.12,3.35 0.02 1.50 0.86,2.64 0.15 
MCVD 4.37 1.27,15.11 0.02 5.06 1.47,17.44 0.01 3.60 1.01,12.77 0.04 
MSRC 2.83 1.32,6.07 0.01 3.11 1.45,6.65 <0.01 2.25 1.04,4.87 0.04 
MALL 2.41 1.46,3.97 <0.01 2.63 1.59,4.33 <0.01 2.01 1.21,3.35 0.01 
1 Model adjusted for age and country of residence (NI / France). 
2 Model adjusted for age, country of residence (NI/France), systolic blood pressure, cholesterol, HDL 
cholesterol, height, BMI, fruit and vegetable intakes (portions of fruit, fruit juice and vegetables / 
day), physical activity (metabolic equivalent scores / week), lifetime smoking (five categories: never 
smoked; smoked other than cigarettes; smoked less than 15 cigarette pack-years; smoked 15 or 
more but less than 30 cigarette pack-years; smoked 30 or more cigarette pack-years), alcohol (five 
categories: none; 1-128ml/week; 129-265ml/week; 266-461ml/week; and 462ml plus/week) and 
diabetes (present/absent). 
  
20 
 
Table 7: Hazards Ratios, Confidence Intervals and significance for depression and disease or 
mortality relationships using grouped data 
  Unadjusted Adjusted for demographic 
variables
1 
Adjusted for demographic 
and lifestyle variables
2 
  HR CI Sig. HR CI Sig. HR CI Sig. 
depVG           
CVDI Q
3 
  0.01   0.01   0.08 
 Q1
4 
1.41 1.08,1.85 0.01 1.44 1.10,1.88 0.01 1.40 1.07,1.83 0.02 
 Q2 1.16 0.83,1.61 0.39 1.18 0.84,1.64 0.34 1.11 0.79,1.55 0.56 
 Q3 1.60 1.13,2.28 0.01 1.62 1.14,2.30 0.01 1.45 1.02,2.06 0.04 
 Q4 1.54 1.12,2.12 0.01 1.60 1.16,2.20 <0.01 1.35 0.97,1.87 0.07 
MCVD Q   0.12   0.08   0.22 
 Q1 1.65 0.80,3.42 0.18 1.70 0.82,3.52 0.15 1.66 0.80,3.46 0.18 
 Q2 2.06 0.95,4.48 0.07 2.13 0.98,4.64 0.06 1.98 0.90,4.35 0.09 
 Q3 2.11 0.86,5.16 0.10 2.17 0.88,5.31 0.09 1.87 0.76,4.62 0.18 
 Q4 2.66 1.24,5.68 0.01 2.84 1.33,6.08 0.01 2.42 1.11,5.31 0.03 
MSRC Q   <0.01   <0.01   0.04 
 Q1 1.07 0.69,1.66 0.77 1.09 0.70,1.68 0.72 1.04 0.67,1.61 0.87 
 Q2 1.80 1.17,2.77 0.01 1.84 1.20,2.83 0.01 1.68 1.09,2.58 0.02 
 Q3 1.70 1.02,2.85 0.04 1.73 1.04,2.90 0.04 1.49 0.88,2.49 0.14 
 Q4 2.01 1.29,3.11 <0.01 2.11 1.36,3.27 <0.01 1.69 1.08,2.65 0.02 
MALL Q   <0.01   <0.01   <0.01 
 Q1 1.07 0.82,1.41 0.61 1.09 0.83,1.43 0.55 1.05 0.80,1.39 0.72 
 Q2 1.37 1.02,1.84 0.04 1.40 1.04,1.88 0.03 1.31 0.98,1.76 0.07 
 Q3 1.77 1.29,2.44 <0.01 1.81 1.32,2.49 <0.01 1.60 1.16,2.20 <0.01 
 Q4 1.82 1.37,2.42 <0.01 1.92 1.45,2.55 <0.01 1.63 1.22,2.18 <0.01 
DEPFAG           
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CVDI Q   0.43   0.31   0.76 
 Q1 0.96 0.69,1.35 0.82 0.99 0.70,1.38 0.93 1.06 0.76,1.48 0.74 
 Q2 1.09 0.78,1.52 0.60 1.11 0.80,1.54 0.54 1.13 0.82,1.58 0.46 
 Q3 1.18 0.86,1.63 0.32 1.20 0.87,1.65 0.27 1.14 0.83,1.58 0.42 
 Q4 1.27 0.93,1.75 0.14 1.34 0.97,1.84 0.08 1.24 0.90,1.71 0.20 
MCVD Q   0.13   0.10   0.23 
 Q1 0.31 0.10,0.95 0.04 0.33 0.11,0.99 0.05 0.36 0.12,1.11 0.08 
 Q2 0.90 0.41,1.99 0.80 0.93 0.42,2.06 0.87 0.95 0.43,2.12 0.91 
 Q3 1.13 0.54,2.38 0.74 1.18 0.56,2.47 0.67 1.14 0.54,2.40 0.74 
 Q4 1.36 0.66,2.78 0.40 1.49 0.73,3.06 0.28 1.37 0.65,2.86 0.41 
MSRC Q   0.03   0.02   0.08 
 Q1 0.78 0.47,1.31 0.35 0.80 0.48,1.34 0.40 0.81 0.48,1.35 0.41 
 Q2 0.82 0.49,1.38 0.46 0.83 0.50,1.39 0.49 0.81 0.49,1.36 0.43 
 Q3 1.46 0.94,2.27 0.10 1.48 0.95,2.30 0.08 1.37 0.88,2.14 0.16 
 Q4 1.39 0.89,2.19 0.15 1.48 0.94,2.32 0.09 1.30 0.83,2.06 0.26 
MALL Q   0.01   <0.01   0.06 
 Q1 0.80 0.58,1.11 0.19 0.82 0.59,1.13 0.23 0.82 0.59,1.13 0.23 
 Q2 0.96 0.71,1.32 0.82 0.97 0.71,1.33 0.86 0.94 0.69,1.29 0.72 
 Q3 1.20 0.89,1.61 0.23 1.21 0.90,1.63 0.21 1.14 0.85,1.53 0.38 
 Q4 1.36 1.02,1.81 0.04 1.43 1.07,1.92 0.02 1.29 0.96,1.73 0.09 
1 Model adjusted for age and country of residence (NI / France). 
2 Model adjusted for age, country of residence (NI/France), systolic blood pressure, cholesterol, HDL 
cholesterol, height, BMI, fruit and vegetable intakes (portions of fruit, fruit juice and vegetables / 
day), physical activity (metabolic equivalent scores / week), lifetime smoking (five categories: never 
smoked; smoked other than cigarettes; smoked less than 15 cigarette pack-years; smoked 15 or 
more but less than 30 cigarette pack-years; smoked 30 or more cigarette pack-years), alcohol (five 
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categories: none; 1-128ml/week; 129-265ml/week; 266-461ml/week; and 462ml plus/week) and 
diabetes (present/absent). 
3 significance value for a linear trend 
4 coefficient, confidence intervals and significance values for each group compared to the reference 
group – no depression. 
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Figure 1: Scatterplots demonstrating the relationship between DepV and DepFA in France and 
Northern Ireland.  
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